• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, November 13, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Artificial intelligence could predict spread of melanoma

Bioengineer by Bioengineer
February 26, 2019
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Study conducted by Ben-Gurion University and Texas Southwestern Medical Center

BEER-SHEVA, Israel…February 26, 2019 – An interdisciplinary team of researchers at Ben-Gurion University of the Negev (BGU) in Israel and the University of Texas Southwestern Medical Center (UTSW) in Dallas have developed groundbreaking technology to identify melanoma cells that are likely to metastasize to other parts of the body using artificial intelligence (AI).

The method, called “quantitative live cell histology,” was presented recently at the American Society for Cell Biology/EMBO conference in San Diego by Dr. Assaf Zaritsky, of the BGU Department of Software and Information Systems Engineering, and UTSU Prof. Gaudenz Danuser.

The technology records video of cells using microscopic cameras and identifies the appearance and behavioral patterns of those cells that have metastatic potential.

The group demonstrated that their representation of the functional state of individual cells can predict the likelihood that a stage III melanoma, with malignancies limited to the lymphatic system, will progress to stage IV, in which the cancer has spread from the principal area to the rest of the patient’s body.

“Beyond metastasis prediction potential, the computer models also allowed us to distinguish between cancer cells taken from different patients by quantifying factors that are not visible to the naked eye,” says Dr. Zaritsky.

###

About American Associates, Ben-Gurion University of the Negev

American Associates, Ben-Gurion University of the Negev (AABGU) plays a vital role in sustaining David Ben-Gurion’s vision: creating a world-class institution of education and research in the Israeli desert, nurturing the Negev community and sharing the University’s expertise locally and around the globe. As Ben-Gurion University of the Negev (BGU) looks ahead to turning 50 in 2020, AABGU imagines a future that goes beyond the walls of academia. It is a future where BGU invents a new world and inspires a vision for a stronger Israel and its next generation of leaders. Together with supporters, AABGU will help the University foster excellence in teaching, research and outreach to the communities of the Negev for the next 50 years and beyond. Visit vision.aabgu.org to learn more.

AABGU, headquartered in Manhattan, has nine regional offices throughout the United States. For more information visit https://aabgu.org/.

Media Contact
Andrew Lavin
andrewlavin@alavin.com

Tags: Health CareMedicine/HealthNanotechnology/MicromachinesOpticsRobotry/Artificial Intelligence
Share12Tweet8Share2ShareShareShare2

Related Posts

Omalizumab Eliminates Food-Related Epinephrine Use in Alpha-Gal Syndrome Cohort Study

Omalizumab Eliminates Food-Related Epinephrine Use in Alpha-Gal Syndrome Cohort Study

November 13, 2026
Liquid Biopsy Confirms Complete Remission in Rare Mediastinal Seminoma Case

Liquid Biopsy Confirms Complete Remission in Rare Mediastinal Seminoma Case

November 13, 2026

Study Identifies HER2 Expression as Potential Target in Rare Sarcoma Patients

November 13, 2026

Coupled Regulatory Tools Link to Service Improvements in Chinese Public Hospital Study

November 13, 2026
Please login to join discussion

POPULAR NEWS

  • Childhood Maltreatment and Genetic Risk Independently Predict Adolescent Self-Injury

    Childhood Maltreatment and Genetic Risk Independently Predict Adolescent Self-Injury

    29 shares
    Share 12 Tweet 7
  • Ivabradine and MEL55A Hybrids Inhibit HCN Channels and Pacemaking Activity

    29 shares
    Share 12 Tweet 7
  • Yangtze River Delta Study Unveils Dynamic Coupling of Innovation and Aging Pressure

    29 shares
    Share 12 Tweet 7
  • Severe Postoperative Fatigue Linked to Brain Dysfunction After Acute Aortic Surgery

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Omalizumab Eliminates Food-Related Epinephrine Use in Alpha-Gal Syndrome Cohort Study

Temporal Hypergraph Analysis Uncovers Group Homophily Hidden by Static Network Models

Dynamic Routing Perception-Decision Machine Evaluates Fake Speech Across Three Detection Benchmarks

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 86 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.